专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US5889006A Muscarinic antagonists 失效
标题翻译：毒蕈碱拮抗剂
公开(公告)号：US5889006A
公开(公告)日：1999-03-30
申请号：US700628
申请日：1996-08-08
申请人： Derek B. Lowe , Wei K. Chang , Joseph A. Kozlowski , Joel G. Berger , Robert McQuade , Allen Barnett , Margaret Sherlock , Wing Tom , Sundeep Dugar , Lian-Yong Chen , John W. Clader , Samuel Chackalamannil , Yuguang Wang , Stuart W. McCombie , Jayaram R. Tagat , Susan F. Vice , Wayne Vaccaro , Michael J. Green , Margaret E. Browne , Theodros Asberom , Craig D. Boyle
发明人： Derek B. Lowe , Wei K. Chang , Joseph A. Kozlowski , Joel G. Berger , Robert McQuade , Allen Barnett , Margaret Sherlock , Wing Tom , Sundeep Dugar , Lian-Yong Chen , John W. Clader , Samuel Chackalamannil , Yuguang Wang , Stuart W. McCombie , Jayaram R. Tagat , Susan F. Vice , Wayne Vaccaro , Michael J. Green , Margaret E. Browne , Theodros Asberom , Craig D. Boyle
IPC分类号： C07D211/58 , A61K31/00 , A61K31/435 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/445 , A61K31/4465 , A61K31/4523 , A61K31/4545 , A61K31/47 , A61K31/4709 , A61K31/495 , A61K31/496 , A61K31/50 , A61K31/501 , A61K45/00 , A61P25/28 , C07D211/24 , C07D211/32 , C07D211/96 , C07D239/34 , C07D257/04 , C07D295/02 , C07D295/03 , C07D295/084 , C07D295/088 , C07D295/096 , C07D295/112 , C07D295/116 , C07D295/125 , C07D295/13 , C07D295/135 , C07D295/145 , C07D295/15 , C07D401/04 , C07D401/10 , C07D401/12 , C07D401/14 , C07D405/12 , C07D405/14 , C07D409/14 , C07D413/14 , C07D401/02 , C07D403/02 , C07D403/14
CPC分类号： C07D405/14 , C07D211/24 , C07D211/32 , C07D239/34 , C07D257/04 , C07D295/03 , C07D295/088 , C07D295/092 , C07D295/096 , C07D295/112 , C07D295/116 , C07D295/125 , C07D295/13 , C07D295/135 , C07D295/145 , C07D295/15 , C07D405/12 , C07D409/14 , C07C2101/14
摘要： Di-N-substituted piperazine or 1,4 di-substituted piperadine compounds in accordance with formula I (including all isomers, salts, esters, and solvates) ##STR1## wherein R, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.21, R.sup.27, R.sup.28, X, Y, and Z are as defined herein are muscarinic antagonists useful for treating cognitive disorders such as Alzheimer's disease. Pharmaceutical compositions and methods of preparation are also disclosed. Also disclosed are synergistic combinations of compounds of the above formula with acetylcholinesterase inhibitors.
摘要翻译：根据式I的二-N-取代哌嗪或1,4-二取代哌啶化合物（包括所有异构体，盐，酯和溶剂合物）其中R，R 1，R 2，R 3，R 4，R 21，R 27 R28，X，Y和Z如本文所定义的是可用于治疗认知障碍如阿尔茨海默病的毒蕈碱性拮抗剂。还公开了药物组合物和制备方法。还公开了上式化合物与乙酰胆碱酯酶抑制剂的协同组合。

2. 发明授权

US6043255A Muscarinic antagonists 失效
标题翻译：毒蕈碱拮抗剂
公开(公告)号：US6043255A
公开(公告)日：2000-03-28
申请号：US266079
申请日：1999-03-10
申请人： Derek B. Lowe , Wei K. Chang , Joseph A. Kozlowski , Joel G. Berger , Robert McQuade , Allen Barnett , Margaret Sherlock , Wing Tom , Sundeep Dugar , Lian-Yong Chen , John W Clader , Samuel Chackalamannil , Yuguang Wang , Stuart W. McCombie , Jayaram R. Tagat , Susan F. Vice , Wayne Vaccaro , Michael J. Green , Margaret E. Browne , Theodros Asberom , Craig D. Boyle
发明人： Derek B. Lowe , Wei K. Chang , Joseph A. Kozlowski , Joel G. Berger , Robert McQuade , Allen Barnett , Margaret Sherlock , Wing Tom , Sundeep Dugar , Lian-Yong Chen , John W Clader , Samuel Chackalamannil , Yuguang Wang , Stuart W. McCombie , Jayaram R. Tagat , Susan F. Vice , Wayne Vaccaro , Michael J. Green , Margaret E. Browne , Theodros Asberom , Craig D. Boyle
IPC分类号： C07D211/58 , A61K31/00 , A61K31/435 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/445 , A61K31/4465 , A61K31/4523 , A61K31/4545 , A61K31/47 , A61K31/4709 , A61K31/495 , A61K31/496 , A61K31/50 , A61K31/501 , A61K45/00 , A61P25/28 , C07D211/24 , C07D211/32 , C07D211/96 , C07D239/34 , C07D257/04 , C07D295/02 , C07D295/03 , C07D295/084 , C07D295/088 , C07D295/096 , C07D295/112 , C07D295/116 , C07D295/125 , C07D295/13 , C07D295/135 , C07D295/145 , C07D295/15 , C07D401/04 , C07D401/10 , C07D401/12 , C07D401/14 , C07D405/12 , C07D405/14 , C07D409/14 , C07D413/14 , C07D401/02
CPC分类号： C07D405/14 , C07D211/24 , C07D211/32 , C07D239/34 , C07D257/04 , C07D295/03 , C07D295/088 , C07D295/092 , C07D295/096 , C07D295/112 , C07D295/116 , C07D295/125 , C07D295/13 , C07D295/135 , C07D295/145 , C07D295/15 , C07D405/12 , C07D409/14 , C07C2101/14
摘要： Di-N-substituted piperazine or 1,4 di-substituted piperadine compounds in accordance with formula I (including all isomers, salts, esters, and solvates) ##STR1## wherein R, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.21, R.sup.27, R.sup.28, X, Y, and Z are as defined herein are muscarinic antagonists useful for treating cognitive disorders such as Alzheimer's disease. Pharmaceutical compositions and methods of preparation are also disclosed. Also disclosed are synergistic combinations of compounds of the above formula with acetylcholinesterase inhibitors.
摘要翻译：根据式I的二-N-取代哌嗪或1,4-二取代哌嗪化合物（包括所有异构体，盐，酯和溶剂合物），其中R，R 1，R 2，R 3，R 4，R 21，R 27，R 28，X Y和Z如本文所定义的是可用于治疗认知障碍如阿尔茨海默氏病的毒蕈碱拮抗剂。还公开了药物组合物和制备方法。还公开了上式化合物与乙酰胆碱酯酶抑制剂的协同组合。

3. 发明授权

US5935958A Muscarinic antagonists 失效
标题翻译：毒蕈碱拮抗剂
公开(公告)号：US5935958A
公开(公告)日：1999-08-10
申请号：US883183
申请日：1997-06-26
申请人： Joseph A. Kozlowski , Derek B. Lowe , Wei K. Chang , Sundeep Dugar
发明人： Joseph A. Kozlowski , Derek B. Lowe , Wei K. Chang , Sundeep Dugar
IPC分类号： C07D211/58 , C07D239/34 , C07D295/096 , C07D311/74 , A61K31/495 , A61K31/445 , C07D401/12 , C07D405/14
CPC分类号： C07D295/096 , C07D211/58 , C07D239/34 , C07D311/74
摘要： Di-N-substituted piperazine or 1,4-di-substituted piperidine compounds in accordance with formula I (including all isomers, salts, esters, and solvates) ##STR1## wherein Q, n, R, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.21, R.sup.27, R.sup.28, X, and Z are as defined herein are muscarinic antagonists useful for treating cognitive disorders such as Alzheimer's disease. Pharmaceutical compositions and methods of preparation are also disclosed. Also disclosed are synergistic combinations with acetyl-cholinesterase inhibitors of compounds capable of enhancing acetylcholine release and having the above formula.
摘要翻译：根据式I的二-N-取代哌嗪或1,4-二取代哌啶化合物（包括所有异构体，盐，酯和溶剂化物）其中Q，n，R，R1，R2，R3，R4，R21， R27，R28，X和Z如本文所定义的是可用于治疗认知障碍如阿尔茨海默氏病的毒蕈碱拮抗剂。还公开了药物组合物和制备方法。还公开了与能够增强乙酰胆碱释放并具有上式的化合物的乙酰胆碱酯酶抑制剂的协同组合。

4. 发明授权

US5952349A Muscarinic antagonists for treating memory loss 失效
标题翻译：毒蕈碱拮抗剂治疗记忆丧失
公开(公告)号：US5952349A
公开(公告)日：1999-09-14
申请号：US889486
申请日：1997-07-08
申请人： Theodros Asberom , Derek B. Lowe , Michael J. Green
发明人： Theodros Asberom , Derek B. Lowe , Michael J. Green
IPC分类号： C07D211/58 , A61K31/445 , C07D401/04
CPC分类号： C07D211/58
摘要： 1,4 Di-substituted piperidine muscarinic antagonists of formula I ##STR1## or a pharmaceutically acceptable salt, ester, or solvate thereof, wherein X is a bond, --O--, --SO.sub.0-2 --, --CO--, --C(OR.sup.7).sub.2 --, --CH.sub.2 --O--, --O--CH.sub.2 --, --CH.dbd.CH--, --CH.sub.2 --, --CH(C.sub.1 --C.sub.6 alkyl)--, --C(C.sub.1 --C.sub.6 alkyl).sub.2 --, --CONR.sup.17 --, --NR.sup.17 CO--, --SO.sub.2 NR.sup.17 -- or --NR.sup.17 SO.sub.2 --; R is C.sub.3 --C.sub.6 cycloalkyl, optionally substituted phenyl or optionally substituted pyridyl; R.sup.1 is H, --CN, --CF.sub.3, alkyl, cycloalkyl, cycloalkenyl, alkenyl, --COR.sup.15, --COO(alkyl, aryl, heteroaryl, alkylaryl or alkylheteroaryl), alkylaryl, alkylheteroaryl or --CON(R.sup.13).sub.2 ; R.sup.2 is cycloalkyl, cycloalkenyl, t-butoxycarbonyl or optionally substituted 4-piperidinyl; and R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.13, R.sup.15 and R.sup.17 are as defined in the specification are disclosed as being useful for treating cognitive disorders such as Alzheimer's disease; also disclosed are pharmaceutical compositions, methods of preparation and combinations of compounds of formula I capable of enhancing ACh release with ACh'ase inhibitors.
摘要翻译： 1,4-二取代的式I的哌啶毒蕈碱拮抗剂或其药学上可接受的盐，酯或溶剂化物，其中X为-O-，-SO 2 - ， - CO - ， - C（OR 7）2 - ， - CH 2 -CH 2 - ， - CH = CH - ， - CH 2 - ， - CH（C 1 -C 6烷基） - ， - （C 1 -C 6烷基） NR 17 CO - ， - SO 2 NR 17 - 或-NR 17 SO 2 - ; R为C 3 -C 6环烷基，任选取代的苯基或任选取代的吡啶基; R 1是H，-CN，-CF 3，烷基，环烷基，环烯基，烯基，-COR 15，-COO（烷基，芳基，杂芳基，烷基芳基或烷基杂芳基），烷基芳基，烷基杂芳基或-CON（R 13） R2是环烷基，环烯基，叔丁氧基羰基或任选取代的4-哌啶基; R 3，R 4，R 5，R 6，R 7，R 13，R 15和R 17如本说明书中所定义，可用于治疗认知障碍如阿尔茨海默病; 还公开了能够与ACh酶抑制剂一起增强ACh释放的药物组合物，制备方法和式I化合物的组合。

5. 发明授权

US06784167B2 17-beta-hydroxysteroid dehydrogenase-II inhibitors 失效
标题翻译： 17-β-羟基类固醇脱氢酶II抑制剂
公开(公告)号：US06784167B2
公开(公告)日：2004-08-31
申请号：US09967430
申请日：2001-09-28
申请人： Jill E. Wood , Jeremy L. Baryza , Catherine R. Brennan , Soongyu Choi , James H. Cook , Brian R. Dixon , Paul P. Ehrlich , David E. Gunn , Ian McAlexander , Peiying Liu , Derek B. Lowe , Anikó M. Redman , William J. Scott , Yamin Wang
发明人： Jill E. Wood , Jeremy L. Baryza , Catherine R. Brennan , Soongyu Choi , James H. Cook , Brian R. Dixon , Paul P. Ehrlich , David E. Gunn , Ian McAlexander , Peiying Liu , Derek B. Lowe , Anikó M. Redman , William J. Scott , Yamin Wang
IPC分类号： A61K3140
CPC分类号： C07D207/26 , C07D207/325 , C07D403/06 , C07D405/06 , C07D409/04 , C07D409/06 , C07D417/06
摘要： 17-beta-hydroxysteroid dehydrogenase-II inhibitors having the structural formula wherein the phenyl group labeled A and the group —C(R4)(R6)Y are oriented cis to each other; W represents O or S; R1 represents —H or optionally substituted —(C1-C4)alkyl; n represents 0 or an integer of 1-3; and R2 represents any of a variety of substituents on ring A. R4 generally represents —H but may be a bond terminating at the ortho position of ring A. Y represents fluorine, —OR5, or —SR5, and R5 represents —H, optionally substituted —(C1-C4)alkyl, optionally substituted -phenyl, optionally substituted —(C1-C4)alkyl-phenyl, or optionally substituted —(C1-C4)acyl. R6 represents any of a variety of groups as defined in the specification and claims, including heteroaryl, arylalkyl, heteroarylalkyl, arylalkenyl, heteroarylalkenyl, alkynyl, arylalkynyl, heteroarylalkynyl, aryl, and indolyl. Pharmaceutically acceptable salts and N-oxides of these materials are also included. Also claimed are pharmaceutical compositions containing these materials and methods of using them.
摘要翻译：具有被标记为A的苯基的基团的结构式-17-β-羟基类固醇脱氢酶II抑制剂和基团-C（R 4）（R 6）Y取代为彼此顺式; W表示O或S; R 1表示-H或任选取代的 - （C 1 -C 4）烷基; n表示0或1-3的整数; 并且R 2代表环A上的任何取代基.R 4通常表示-H，但可以是在环A的邻位终止的键.Y表示氟，-OR 5或 - （C 1 -C 4）烷基，任选取代的 - 苯基，任选取代的（C 1 -C 4）烷基 - 苯基或任选取代的 - （C 1 -C 4）酰基。 R 6表示说明书和权利要求中定义的各种基团中的任何一种，包括杂芳基，芳基烷基，杂芳基烷基，芳基烯基，杂芳基烯基，炔基，芳基炔基，杂芳基炔基，芳基和吲哚基。也包括这些材料的药学上可接受的盐和N-氧化物。还要求保护的是含有这些材料的药物组合物和使用它们的方法。

6. 发明申请

US20110152330A1 INDANE ACETIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICAL AGENTS, INTERMEDIATES, AND METHOD OF PREPARATION 有权
公开(公告)号：US20110152330A1
公开(公告)日：2011-06-23
申请号：US13035625
申请日：2011-02-25
申请人： Derek B. Lowe , Philip L. Wickens , Xin Ma , Mingbao Zhang , William H. Bullock , Philip D. G. Coish , Ingo A. Mugge , Andreas Stolle , Ming Wang , Yamin Wang , Chengzhi Zhang , Hai-Jun Zhang , Lei Zhu , Manami Tsutsumi , James N. Livingston
发明人： Derek B. Lowe , Philip L. Wickens , Xin Ma , Mingbao Zhang , William H. Bullock , Philip D. G. Coish , Ingo A. Mugge , Andreas Stolle , Ming Wang , Yamin Wang , Chengzhi Zhang , Hai-Jun Zhang , Lei Zhu , Manami Tsutsumi , James N. Livingston
IPC分类号： A61K31/421 , C07D263/32 , A61P3/04 , A61P3/10 , A61P9/00 , A61P9/12 , A61P3/06 , A61P17/00 , A61P35/00
CPC分类号： C07D277/32 , C07B2200/07 , C07C51/412 , C07C51/44 , C07C59/72 , C07C69/732 , C07C69/734 , C07C69/738 , C07C2602/08 , C07D263/32 , C07D277/24 , C07D277/40 , C07D413/04 , C07D413/10 , C07D413/12
摘要： This invention relates to novel indane acetic acid derivatives which are useful in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases. The invention also relates to intermediates useful in preparation of indane acetic derivatives and to methods of preparation.

7. 发明申请

US20090047687A1 Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of Preparation 审中-公开
标题翻译：吲哚乙酸衍生物及其作为药剂，中间体和制备方法的用途
公开(公告)号：US20090047687A1
公开(公告)日：2009-02-19
申请号：US12059706
申请日：2008-03-31
申请人： Derek B. Lowe , Philip L. Wickens , Xin Ma , Mingbao Zhang , William H. Bullock , Philip D. G. Coish , Ingo A. Mugge , Andreas Stolle , Ming Wang , Yamin Wang , Chengzhi Zhang , Hai-Jun Zhang , Lei Zhu , Manami Tsutsumi , James N. Livingston
发明人： Derek B. Lowe , Philip L. Wickens , Xin Ma , Mingbao Zhang , William H. Bullock , Philip D. G. Coish , Ingo A. Mugge , Andreas Stolle , Ming Wang , Yamin Wang , Chengzhi Zhang , Hai-Jun Zhang , Lei Zhu , Manami Tsutsumi , James N. Livingston
IPC分类号： G01N33/53 , C07C69/76 , C07C63/00 , C07D263/30 , C07D277/20 , C07C229/00
CPC分类号： C07D277/32 , C07B2200/07 , C07C51/412 , C07C51/44 , C07C59/72 , C07C67/303 , C07C69/732 , C07C69/734 , C07C69/738 , C07C2602/08 , C07D263/32 , C07D277/24 , C07D277/40 , C07D413/04 , C07D413/10 , C07D413/12 , Y02P20/582
摘要： This invention relates to novel indane acetic acid derivatives which are useful in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases. The invention also relates to intermediates useful in preparation of indane acetic derivatives and to methods of preparation.
摘要翻译：本发明涉及可用于治疗疾病如糖尿病，肥胖症，高脂血症和动脉粥样硬化疾病的新型茚满乙酸衍生物。本发明还涉及可用于制备茚满乙酸衍生物的中间体及其制备方法。

8. 发明授权

US06787651B2 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-&ggr; binding agents 失效
标题翻译：取代的吲哚，含有这种吲哚的药物化合物及其作为PPAR-γ结合剂的用途
公开(公告)号：US06787651B2
公开(公告)日：2004-09-07
申请号：US09974319
申请日：2001-10-09
申请人： Andreas Stolle , Jacques P. Dumas , William Carley , Philip D. G. Coish , Steven R. Magnuson , Yamin Wang , Dhanapalan Nagarathnam , Derek B. Lowe , Ning Su , William H. Bullock , Ann-Marie Campbell , Ning Qi , Jeremy L. Baryza , James H. Cook
发明人： Andreas Stolle , Jacques P. Dumas , William Carley , Philip D. G. Coish , Steven R. Magnuson , Yamin Wang , Dhanapalan Nagarathnam , Derek B. Lowe , Ning Su , William H. Bullock , Ann-Marie Campbell , Ning Qi , Jeremy L. Baryza , James H. Cook
IPC分类号： C07D20934
CPC分类号： C07D401/12 , A61K31/404 , A61K31/407 , A61K31/423 , A61K31/427 , A61K31/4709 , A61K31/496 , A61K31/5377 , C07D209/12 , C07D209/42 , C07D209/48 , C07D403/12 , C07D405/04 , C07D405/10 , C07D405/12 , C07D409/04 , C07D413/04 , C07D413/12 , C07D417/04 , C07D417/12 , C07D417/14 , C07D491/04
摘要： Disclosed are substituted indoles, pharmaceutical compositions containing such indoles, and their use in treating or preventing PPAR-&ggr; mediated diseases or conditions, such as osteopenia, osteoporosis, cancer, diabetes and atherosclerosis.
摘要翻译：公开了取代的吲哚，含有这种吲哚的药物组合物，以及它们在治疗或预防PPAR-γ介导的疾病或病症如骨质减少，骨质疏松症，癌症，糖尿病和动脉粥样硬化中的用途。

9. 发明授权

US08552203B2 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation 有权
公开(公告)号：US08552203B2
公开(公告)日：2013-10-08
申请号：US13035638
申请日：2011-02-25
申请人： Derek B. Lowe , Philip L. Wickens , Xin Ma , Mingbao Zhang , William H. Bullock , Philip D. G. Coish , Ingo A. Mugge , Andreas Stolle , Ming Wang , Yamin Wang , Chengzhi Zhang , Hai-Jun Zhang , Lei Zhu , Manami Tsutsumi , James N. Livingston
发明人： Derek B. Lowe , Philip L. Wickens , Xin Ma , Mingbao Zhang , William H. Bullock , Philip D. G. Coish , Ingo A. Mugge , Andreas Stolle , Ming Wang , Yamin Wang , Chengzhi Zhang , Hai-Jun Zhang , Lei Zhu , Manami Tsutsumi , James N. Livingston
IPC分类号： C07D277/22 , C07D263/30
CPC分类号： C07D277/32 , C07B2200/07 , C07C51/412 , C07C51/44 , C07C59/72 , C07C69/732 , C07C69/734 , C07C69/738 , C07C2602/08 , C07D263/32 , C07D277/24 , C07D277/40 , C07D413/04 , C07D413/10 , C07D413/12
摘要： This invention relates to novel indane acetic acid derivatives which are useful in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases. The invention also relates to intermediates useful in preparation of indane acetic derivatives and to methods of preparation.

10. 发明申请

US20110065129A1 INDANE ACETIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICAL AGENTS, INTERMEDIATES, AND METHOD OF PREPARATION 审中-公开
标题翻译：吲哚乙酸衍生物及其作为药物代谢物，中间体和制备方法的用途
公开(公告)号：US20110065129A1
公开(公告)日：2011-03-17
申请号：US12369736
申请日：2009-02-11
申请人： Derek B. Lowe , Philip L. Wickens , Xin Ma , Mingbao Zhang , William H. Bullock , Philip D. G. Coish , Ingo A. Mugge , Andreas Stolle , Ming Wang , Yamin Wang , Chengzhi Zhang , Hai-Jun Zhang , Lei Zhu , Manami Tsutsumi , James N. Livingston
发明人： Derek B. Lowe , Philip L. Wickens , Xin Ma , Mingbao Zhang , William H. Bullock , Philip D. G. Coish , Ingo A. Mugge , Andreas Stolle , Ming Wang , Yamin Wang , Chengzhi Zhang , Hai-Jun Zhang , Lei Zhu , Manami Tsutsumi , James N. Livingston
IPC分类号： G01N33/567 , C07C51/36 , C07D263/32 , C07D413/12 , C07D413/10 , C07D277/30 , C07D417/10
CPC分类号： C07D277/32 , C07B2200/07 , C07C51/412 , C07C51/44 , C07C59/72 , C07C69/732 , C07C69/734 , C07C69/738 , C07C2602/08 , C07D263/32 , C07D277/24 , C07D277/40 , C07D413/04 , C07D413/10 , C07D413/12
摘要： This invention relates to novel indane acetic acid derivatives which are useful in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases. The invention also relates to intermediates useful in preparation of indane acetic derivatives and to methods of preparation.
摘要翻译：本发明涉及可用于治疗疾病如糖尿病，肥胖症，高脂血症和动脉粥样硬化疾病的新型茚满乙酸衍生物。本发明还涉及可用于制备茚满乙酸衍生物的中间体及其制备方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式